Evidence-Based Medicine Guidelines
Botulinum toxin type A in the treatment of limb spasticity in children with cerebral palsy
Botulinum toxin type A in the treatment of limb spasticity in children with cerebral palsy is a topic covered in the Evidence-Based Medicine Guidelines.
To view the entire topic, please log in or purchase a subscription.
Evidence Central is an integrated web and mobile solution that helps clinicians quickly answer etiology, diagnosis, treatment, and prognosis questions using the latest evidence-based research. Explore these free sample topics:
There's more to see -- the rest of this entry is available only to subscribers.
Citation
"Botulinum Toxin Type a in the Treatment of Limb Spasticity in Children With Cerebral Palsy." Evidence-Based Medicine Guidelines, Duodecim Medical Publications Limited, 2019. Evidence Central, evidence.unboundmedicine.com/evidence/view/EBMG/455161/all/Botulinum_toxin_type_A_in_the_treatment_of_limb_spasticity_in_children_with_cerebral_palsy.
Botulinum toxin type A in the treatment of limb spasticity in children with cerebral palsy. Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2019. https://evidence.unboundmedicine.com/evidence/view/EBMG/455161/all/Botulinum_toxin_type_A_in_the_treatment_of_limb_spasticity_in_children_with_cerebral_palsy. Accessed March 1, 2021.
Botulinum toxin type A in the treatment of limb spasticity in children with cerebral palsy. (2019). In Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited. https://evidence.unboundmedicine.com/evidence/view/EBMG/455161/all/Botulinum_toxin_type_A_in_the_treatment_of_limb_spasticity_in_children_with_cerebral_palsy
Botulinum Toxin Type a in the Treatment of Limb Spasticity in Children With Cerebral Palsy [Internet]. In: Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2019. [cited 2021 March 01]. Available from: https://evidence.unboundmedicine.com/evidence/view/EBMG/455161/all/Botulinum_toxin_type_A_in_the_treatment_of_limb_spasticity_in_children_with_cerebral_palsy.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Botulinum toxin type A in the treatment of limb spasticity in children with cerebral palsy
ID - 455161
BT - Evidence-Based Medicine Guidelines
UR - https://evidence.unboundmedicine.com/evidence/view/EBMG/455161/all/Botulinum_toxin_type_A_in_the_treatment_of_limb_spasticity_in_children_with_cerebral_palsy
PB - Duodecim Medical Publications Limited
DB - Evidence Central
DP - Unbound Medicine
ER -
